These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37190241)

  • 21. Preoperative Radiomics Approach to Evaluating Tumor-Infiltrating CD8
    Bian Y; Liu C; Li Q; Meng Y; Liu F; Zhang H; Fang X; Li J; Yu J; Feng X; Ma C; Zhao Z; Wang L; Xu J; Shao C; Lu J
    J Magn Reson Imaging; 2022 Mar; 55(3):803-814. PubMed ID: 34355834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiating Mass-Forming Autoimmune Pancreatitis From Pancreatic Ductal Adenocarcinoma on the Basis of Contrast-Enhanced MRI and DWI Findings.
    Choi SY; Kim SH; Kang TW; Song KD; Park HJ; Choi YH
    AJR Am J Roentgenol; 2016 Feb; 206(2):291-300. PubMed ID: 26797355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic neuroendocrine tumor: Correlations between MRI features, tumor biology, and clinical outcome after surgery.
    Canellas R; Lo G; Bhowmik S; Ferrone C; Sahani D
    J Magn Reson Imaging; 2018 Feb; 47(2):425-432. PubMed ID: 28480609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
    Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
    Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET.
    Sahani DV; Kalva SP; Fischman AJ; Kadavigere R; Blake M; Hahn PF; Saini S
    AJR Am J Roentgenol; 2005 Jul; 185(1):239-46. PubMed ID: 15972430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular involvement and resectability of pancreatic ductal adenocarcinoma on contrast-enhanced MRI: comparison with pancreatic protocol CT.
    Noda Y; Kawai N; Kaga T; Ishihara T; Hyodo F; Kato H; Kambadakone AR; Matsuo M
    Abdom Radiol (NY); 2022 Aug; 47(8):2835-2844. PubMed ID: 35760922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic impact of tumor perfusion in MR-imaging studies in Ewing tumors.
    Dunst J; Ahrens S; Paulussen M; Burdach S; Jürgens H
    Strahlenther Onkol; 2001 Mar; 177(3):153-9. PubMed ID: 11285773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreatic ductal adenocarcinoma: prevalence and diagnostic value of dark choledochal ring sign on T2-weighted MRI.
    Cha DI; Kim YK; Choi SY; Lim SH; Choi D; Lee WJ
    Clin Radiol; 2014 Apr; 69(4):416-23. PubMed ID: 24457015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiomics Model Based on MR Images to Discriminate Pancreatic Ductal Adenocarcinoma and Mass-Forming Chronic Pancreatitis Lesions.
    Deng Y; Ming B; Zhou T; Wu JL; Chen Y; Liu P; Zhang J; Zhang SY; Chen TW; Zhang XM
    Front Oncol; 2021; 11():620981. PubMed ID: 33842325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of tumour grade and survival outcome using pre-treatment PET- and MRI-derived imaging features in patients with resectable pancreatic ductal adenocarcinoma.
    Dunet V; Halkic N; Sempoux C; Demartines N; Montemurro M; Prior JO; Schmidt S
    Eur Radiol; 2021 Feb; 31(2):992-1001. PubMed ID: 32851447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative functional MRI in a clinical orthotopic model of pancreatic cancer in immunocompetent Lewis rats.
    Zhang Z; Zheng L; Li W; Gordon AC; Huan Y; Shangguan J; Procissi D; Bentrem DJ; Larson AC
    Am J Transl Res; 2015; 7(9):1475-86. PubMed ID: 26550449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Features and Prognostic Impact of Pancreatic Ductal Adenocarcinoma without Dilatation of the Main Pancreatic Duct: A Single-Center Retrospective Analysis.
    Takayanagi T; Sekino Y; Kasuga N; Ishii K; Nagase H; Nakajima A
    Diagnostics (Basel); 2023 Mar; 13(5):. PubMed ID: 36900107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular volume fraction determined by equilibrium contrast-enhanced dual-energy CT as a prognostic factor in patients with stage IV pancreatic ductal adenocarcinoma.
    Fukukura Y; Kumagae Y; Higashi R; Hakamada H; Nakajo M; Maemura K; Arima S; Yoshiura T
    Eur Radiol; 2020 Mar; 30(3):1679-1689. PubMed ID: 31728691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver metastases in pancreatic ductal adenocarcinoma: a predictive model based on CT texture analysis.
    De Robertis R; Geraci L; Tomaiuolo L; Bortoli L; Beleù A; Malleo G; D'Onofrio M
    Radiol Med; 2022 Oct; 127(10):1079-1084. PubMed ID: 36057929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatobiliary contrast uptake patterns on gadoxetic acid-enhanced MRI in liver metastases from pancreatic ductal adenocarcinoma: can it predict prognosis?
    Noda Y; Tochigi T; Baliyan V; Kordbacheh H; Kambadakone A
    Eur Radiol; 2021 Jan; 31(1):276-282. PubMed ID: 32783131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravoxel incoherent motion DWI of the pancreatic adenocarcinomas: monoexponential and biexponential apparent diffusion parameters and histopathological correlations.
    Ma C; Li Y; Wang L; Wang Y; Zhang Y; Wang H; Chen S; Lu J
    Cancer Imaging; 2017 Apr; 17(1):12. PubMed ID: 28454564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiating pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas by the "Duct-Road Sign": A preliminary magnetic resonance imaging study.
    Xiao B; Jiang ZQ; Hu JX; Zhang XM; Xu HB
    Medicine (Baltimore); 2019 Aug; 98(35):e16960. PubMed ID: 31464937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole-tumour evaluation with MRI and radiomics features to predict the efficacy of S-1 for adjuvant chemotherapy in postoperative pancreatic cancer patients: a pilot study.
    Liang L; Ding Y; Yu Y; Liu K; Rao S; Ge Y; Zeng M
    BMC Med Imaging; 2021 Apr; 21(1):75. PubMed ID: 33902469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiparametric MR imaging detects therapy efficacy of radioactive seeds brachytherapy in pancreatic ductal adenocarcinoma xenografts.
    Liu Y; Wang Y; Tang W; Jiang M; Li K; Tao X
    Radiol Med; 2018 Jul; 123(7):481-488. PubMed ID: 29508241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Noncontrast Magnetic Resonance Radiomics and Multilayer Perceptron Network Classifier: An approach for Predicting Fibroblast Activation Protein Expression in Patients With Pancreatic Ductal Adenocarcinoma.
    Meng Y; Zhang H; Li Q; Xing P; Liu F; Cao K; Fang X; Li J; Yu J; Feng X; Ma C; Wang L; Jiang H; Lu J; Bian Y; Shao C
    J Magn Reson Imaging; 2021 Nov; 54(5):1432-1443. PubMed ID: 33890347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.